Dongfeng Wu

Prof. Dongfeng Wu

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Lung Cancer
Verified
Journal Article
Closed access
Dongfeng WuDongfeng Wu
Dongfeng Wu
DEDiane Erwin
Diane Erwin
GRGary L. Rosner
Gary L. Rosner

11 March 2014 in Journal of School Health
Verified
Journal Article
Closed access
PDF file
JLJiying Ling
Jiying Ling
KKKristi M. King
Kristi M. King
BSBarbara J. Speck
Barbara J. Speck
Seongho KimSeongho Kim
Seongho Kim
Dongfeng WuDongfeng Wu
Dongfeng Wu


20 April 2012 in The International Journal of Biostatistics
Verified
Journal Article
Open access
PDF file
Dongfeng WuDongfeng Wu
Dongfeng Wu
KKKaren Kafadar
Karen Kafadar
GRGary L. Rosner
Gary L. Rosner
LBLyle D. Broemeling
Lyle D. Broemeling
This paper extends the previous probability model for the distribution of lead time in periodic cancer screening exams, namely, in that the lifetime T is treated as a random variable, instead of a fixed value. Hence the number of screens for a given individual is a random variable as well. We use the actuarial life table from the Social Security Administration to obtain the lifetime distribution, and then use this information to project the lead time distribution for someone with a future screening schedule. Simulation studies using the HIP study group data provide estimates of the lead time under different screening frequencies. The projected lead time has two components: a point mass at zero (corresponding to interval cases detected between screening exams) and a continuous probability density. We present estimates of the projected lead time for participants in a breast cancer screening program. The model is more realistic and can inform optimal screening frequency. This study focuses on breast cancer screening, but is applicable to other kinds of cancer screening also.

15 August 2008 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
Dongfeng WuDongfeng Wu
Dongfeng Wu
DEDiane Erwin
Diane Erwin
GRGary L. Rosner
Gary L. Rosner

1 January 2013 in Journal of Epidemiology and Global Health
Verified
Journal Article
Open access
HJHyejeong Jang
Hyejeong Jang
Seongho KimSeongho Kim
Seongho Kim
Dongfeng WuDongfeng Wu
Dongfeng Wu
Lung cancer screening using X-rays has been controversial for many years. A major concern is whether lung cancer screening really brings any survival benefits, which depends on effective treatment after early detection. The problem was analyzed from a different point of view and estimates were presented of the projected lead time for participants in a lung cancer screening program using the Johns Hopkins Lung Project (JHLP) data. The newly developed method of lead time estimation was applied where the lifetime T was treated as a random variable rather than a fixed value, resulting in the number of future screenings for a given individual is a random variable. Using the actuarial life table available from the United States Social Security Administration, the lifetime distribution was first obtained, then the lead time distribution was projected using the JHLP data. The data analysis with the JHLP data shows that, for a male heavy smoker with initial screening ages at 50, 60, and 70, the probability of no-early-detection with semiannual screens will be 32.16%, 32.45%, and 33.17%, respectively; while the mean lead time is 1.36, 1.33 and 1.23 years. The probability of no-early-detection increases monotonically when the screening interval increases, and it increases slightly as the initial age increases for the same screening interval. The mean lead time and its standard error decrease when the screening interval increases for all age groups, and both decrease when initial age increases with the same screening interval. The overall mean lead time estimated with a random lifetime T is slightly less than that with a fixed value of T. This result is hoped to be of benefit to improve current screening programs.